CorMedix Inc.

11/18/2024 | Press release | Distributed by Public on 11/18/2024 19:38

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Hurlburt Elizabeth
2. Issuer Name and Ticker or Trading Symbol
CorMedix Inc. [CRMD] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP
(Last) (First) (Middle)
C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200 		3. Date of Earliest Transaction (Month/Day/Year)
11/14/2024
(Street)
BERKELEY HEIGHTS, NJ 07922 		4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/14/2024 M 3 A $1.45 45,400 D
Common Stock 11/14/2024 M 8,169 A $8.30 53,569 D
Common Stock 11/14/2024 M 9,888 A $5.63 63,457 D
Common Stock 11/14/2024 M 34,467 A $4.08 97,924 D
Common Stock 11/14/2024 M 62,500 A $4.43 160,424 D
Common Stock 11/14/2024 M 25,000 A $3.47 185,424 D
Common Stock(1) 11/14/2024(1) (1) S(1) 140,027(1) D(1) $11.1812(1) 45,397(1) D(1) (1)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy Common Stock) $1.45 11/14/2024 M 3 (2) 03/19/2028 Common Stock 3 $ 0 53,997 D
Stock Option (Right to Buy Common Stock) $8.30 11/14/2024 M 8,169 (3) 01/10/2029 Common Stock 8,169 $ 0 12,711 D
Stock Option (Right to Buy Common Stock) $5.63 11/14/2024 M 9,888 (4) 05/11/2030 Common Stock 9,888 $ 0 27,612 D
Stock Option (Right to Buy Common Stock) $4.08 11/14/2024 M 34,467 (5) 05/11/2030 Common Stock 34,467 $ 0 3,033 D
Stock Option (Right to Buy Common Stock) $4.43 11/14/2024 M 62,500 (6) 01/14/2033 Common Stock 62,500 $ 0 62,500 D
Stock Option (Right to Buy Common Stock) $3.47 11/14/2024 M 25,000 (7) 01/11/2034 Common Stock 25,000 $ 0 75,000 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Hurlburt Elizabeth
C/O CORMEDIX INC.
300 CONNELL DRIVE, SUITE 4200
BERKELEY HEIGHTS, NJ 07922 		EVP

Signatures

/s/ Elizabeth Hurlburt 11/18/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
(2) These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones. This option was previously reported as covering 186,000 shares but was adjusted to reflect a reverse stock split that occurred on March 26, 2019.
(3) These options were granted 1/10/2019 and vested as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones.
(4) These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
(5) These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
(6) These options were granted on 1/14/2023. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant and will vest 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
(7) These options were granted on 01/12/2024. These options vested 1/4 on the date of grant, and, subject to continued employment, will vest 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.